Skip to main content
# Title Department Research Year
61 Non-coding RNA-directed therapeutics in lung cancer: Delivery technologies and clinical applications Department of Industrial Pharmacy 2023
62 Phytochemical investigation, molecular docking studies and DFT calculations on the antidiabetic and cytotoxic activities of Gmelina philippensis CHAM Department of Pharmacognosy 2023
63 Combined experimental/computational aspects for the molecular interaction of empagliflozin with bovine serum albumin: Quantification and application to human plasma Department of Medicinal Chemistry 2023
64 Potent anticancer activity of (Z)‑3‑hexenyl‑β‑D‑glucopyranoside in pancreatic cancer cells Department of Pharmacognosy 2023
65 Zinc(II) complexation strategy for ultra‐sensitive fluorimetric estimation of molnupiravir: Applications and greenness evaluation 2023
66 Novel piperine-carboximidamide hybrids: design, synthesis, and antiproliferative activity via a multi-targeted inhibitory pathway Department of Pharmaceutical Organic Chemistry 2022
67 Nucleic acids for gene therapy (book chapter) Department of Pharmaceutics 2022
68 Design, synthesis, and modelling study of new 1,2,3- triazole/chalcone hybrids with antiproliferative action as epidermal growth factor receptor inhibitors Department of Pharmaceutical Organic Chemistry 2022
69 Novel Spiro Hybrids of 2-indolinone and Thiazolodinone Scaffolds as Cell Cycle Checkpoints’ Pathways Regulators with potential anticancer activity Department of Medicinal Chemistry 2022
70 Design and Synthesis of Novel 1,3,4-Oxadiazole and 1,2,4-Triazole Derivatives as Cyclooxygenase-2 Inhibitors with Anti-inflammatory and Antioxidant activity in LPS-stimulated RAW264.7 Macrophages Department of Medicinal Chemistry 2022